ArticleInfection and drug resistance2018
Comparative analysis of
Article in Infection and drug resistance, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- Insights into incompatible plasmids in multidrug-resistant Raoultella superbugs.BMC microbiology · 2025Article
- Molecular mechanisms responsible KPC-135-mediated resistance to ceftazidime-avibactam in ST11-K47 hypervirulentEmerging microbes & infections · 2024Article
- Designing a conjugate vaccine targetingHeliyon · 2024Article
- Fosfomycin resistance mechanisms inFrontiers in cellular and infection microbiology · 2023Review
- Dynamic evolution of ceftazidime-avibactam resistance due to interchanges betweenFrontiers in cellular and infection microbiology · 2023Article
- Epidemiological characteristics ofFrontiers in microbiology · 2023Article
- Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae in China.Genomics, proteomics & bioinformatics · 2022Article
- Transmission of Nonconjugative Virulence or Resistance Plasmids Mediated by a Self-Transferable IncN3 Plasmid from Carbapenem-Resistant Klebsiella pneumoniae.Microbiology spectrum · 2022Article
- Genomic epidemiology and temperature dependency of hypermucoviscousMicrobial genomics · 2022Article
- Molecular and clinical characterization of hypervirulentFrontiers in cellular and infection microbiology · 2022Article
- Tandem Repeat ofInfection and drug resistance · 2022Article
- Multiple-Replicon Resistance Plasmids ofFrontiers in microbiology · 2021Article
- Microbial Characteristics and Genomic Analysis of an ST11 Carbapenem-ResistantFrontiers in public health · 2021Article
- Clonal Dissemination of Clinical Carbapenem-ResistantFrontiers in microbiology · 2021Article
- Article
- Multiple Plasmid Vectors Mediate the Spread ofmSphere · 2020Article
- Novel IncR/IncP6 Hybrid Plasmid pCRE3-KPC Recovered from a Clinical KPC-2-Producing Citrobacter braakii Isolate.mSphere · 2020Article
- Rapid phenotypic evolution in multidrug-resistant Klebsiella pneumoniae hospital outbreak strains.Microbial genomics · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe recently reported the complete sequence of a
methodsA total of 51
resultThe six KPC-encoding plasmids p1068-KPC, p20049-KPC, p12139-KPC and p64917-KPC (sequenced in this study) and p675920-1 and pCT-KPC slightly differed from one another due to deletion and acquisition of various backbone and accessory regions. Two major accessory resistance regions, which included the
conclusionThere was clonal dissemination of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.